Oppenheimer & Co. Inc. decreased its stake in shares of Hanesbrands Inc. (NYSE:HBI – Get Rating) by 15.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 33,800 shares of the textile maker’s stock after selling 6,165 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Hanesbrands were worth $215,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in HBI. Accurate Wealth Management LLC acquired a new position in shares of Hanesbrands during the 4th quarter worth approximately $31,000. Allworth Financial LP increased its position in shares of Hanesbrands by 108.8% during the 4th quarter. Allworth Financial LP now owns 5,195 shares of the textile maker’s stock worth $33,000 after purchasing an additional 2,707 shares during the last quarter. Ronald Blue Trust Inc. increased its position in shares of Hanesbrands by 189.7% during the 4th quarter. Ronald Blue Trust Inc. now owns 4,815 shares of the textile maker’s stock worth $33,000 after purchasing an additional 3,153 shares during the last quarter. UMB Bank n.a. increased its position in shares of Hanesbrands by 106.8% during the 4th quarter. UMB Bank n.a. now owns 5,998 shares of the textile maker’s stock worth $38,000 after purchasing an additional 3,098 shares during the last quarter. Finally, Quadrant Capital Group LLC increased its position in shares of Hanesbrands by 463.9% during the 3rd quarter. Quadrant Capital Group LLC now owns 5,989 shares of the textile maker’s stock worth $42,000 after purchasing an additional 4,927 shares during the last quarter. Institutional investors and hedge funds own 81.87% of the company’s stock.
Wall Street Analyst Weigh In
HBI has been the subject of several research analyst reports. UBS Group reduced their target price on Hanesbrands from $7.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday, March 29th. Citigroup reduced their target price on Hanesbrands from $8.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, February 3rd. Credit Suisse Group reduced their target price on Hanesbrands from $7.00 to $6.00 and set a “neutral” rating for the company in a research note on Friday, February 3rd. SpectralCast reiterated a “maintains” rating on shares of Hanesbrands in a research note on Friday, April 28th. Finally, TheStreet downgraded Hanesbrands from a “c” rating to a “d+” rating in a research note on Thursday, February 2nd. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Hanesbrands has an average rating of “Hold” and a consensus price target of $8.60.
Hanesbrands Stock Performance
Hanesbrands (NYSE:HBI – Get Rating) last released its earnings results on Wednesday, May 3rd. The textile maker reported ($0.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.06). The company had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.36 billion. Hanesbrands had a positive return on equity of 38.23% and a negative net margin of 4.64%. Hanesbrands’s quarterly revenue was down 11.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.34 EPS. Sell-side analysts expect that Hanesbrands Inc. will post 0.34 EPS for the current fiscal year.
Hanesbrands Company Profile
Hanesbrands, Inc engages in the business of designing, manufacturing, sourcing, and selling basic apparel such as T-shirts, bras, panties, shape wear, underwear, socks, and activewear. It operates through the following segments: Innerwear, Activewear, and International. The Innerwear segment includes basic apparel including men’s underwear, women’s panties, children’s underwear, and socks, and intimate apparel such as bras, and shape wear.
Read More
- Get a free copy of the StockNews.com research report on Hanesbrands (HBI)
- FREYR Battery Is An Interesting Play On EVs: At Rock Bottom
- Analysts Upgrade GXO Logistics, Its First Quarter Says It All
- The Bottom Is In For AppLovin; Reversal Is NextÂ
- Exact Sciences Serves Investors Exactly What They Wished For
- Shockwave Medical, Fast Grower, In Boston Scientific’s Sights?
Want to see what other hedge funds are holding HBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hanesbrands Inc. (NYSE:HBI – Get Rating).
Receive News & Ratings for Hanesbrands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanesbrands and related companies with MarketBeat.com's FREE daily email newsletter.